arrow
C

Candyce H. Kroenke

pennsylvania state university
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Data-Driven Discovery of Plant-Based Dietary Subtypes and Their Association With Cancer, Cardiovascular Diseases, and Type 2 Diabetes in Postmenopausal Women: Insights From the Women's Health Initiative

基于数据的植物性饮食亚型发现及其与绝经后女性癌症、心血管疾病和2型糖尿病的关联:来自女性健康倡议的研究启示

2026-08-010
PRE
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I–IIIA breast cancer

I期至IIIA期乳腺癌初始化疗剂量减少及后续治疗实施

Cancer
IF5.1
2026-02-240
PRE
Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings

对识别真实世界环境中化疗相关血液学毒性的方法进行评估

2025-11-010
PRE
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

年龄与Ⅰ期-ⅢA期乳腺癌女性化疗剂量减量的关联

2025-11-010
PRE
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer

了解身体质量指数与接受I-IIIA期乳腺癌治疗女性化疗剂量减少之间的关联

2025-10-290
OA
Evaluation of the Electronic Health Record-Support Social Support Score in Breast Cancer: Comparison of Count and Item Response Theory Scores

电子健康记录支持的社会支持评分在乳腺癌中的评估:计数评分与项目反应理论评分的比较

2025-10-010
PRE
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I–IIIA breast cancer

与常规方案相比,剂量密集化疗在I~IIIA期乳腺癌女性患者中的相关患者特征

2025-07-060
PRE
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study
2025-02-010
PRE
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

在综合医疗保健提供系统中,在i-iiia期乳腺癌中使用NCCN指南化疗方案的前景

2024-08-160
PRE
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer
2024-07-251
PRE
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer
2024-07-060
PRE
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019
2024-06-131
OAAI
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer
2024-04-014
PRE
Low physical function Post-Cancer diagnosis is associated with higher mortality risk in postmenopausal women
2024-03-061
PRE